In an experimental model of gestational hypertension, treatment with naringenin decreased hypertension, serum markers of oxidant stress, inflammation, and serum concentrations of Ang II and ET-1, while NO and SOD were increased (Figure 3) [65]. This evidence concerns the gene AGT and hypertensive disorder.